Sign In

Product Overview

Serum-Free & Animal Component-Free
Engineered to address the unmet demand for safer, compliant culture media across research, clinical, and diagnostic applications.

Broad Compatibility
Supports the cultivation of a wide range of mycobacterial species with consistent, controlled, and reproducible performance.

Cost-Effective Solution
Delivers substantial cost savings compared to conventional serum-based commercial media.

No Cell Clumping
Ensures accurate, reliable, and precise quantification of mycobacterial titers.

Versatile Applications
Well-suited for pre-clinical and clinical research, diagnostics, vaccine development, and therapeutic production.

Scalable & Industry-Ready
Facilitates high-density growth and precise titer measurement, enabling seamless bioprocess scalability.

Regulatory Advantage
Removes reliance on animal-derived components, enhancing safety, regulatory compliance, and global acceptability.

Full Description

MycoClear™ broth is tailor made to fulfill the unmet need of a serum free and animal component free media for research, clinical and diagnostic application in the field of various mycobacterial diseases of humans as well as animals.

Currently, all the existing commercial media for mycobacterial culture contain serum and animal components. MycoClear™ broth provides a controlled and reproducible environment for cultivation of a broad range of mycobacterial species.

The media provides significant cost benefits as compared to other serum based commercial media used for mycobacterial culture.

MycoClear™ broth does not allow cell clumping, a common phenomenon that interferes with the quantification of the organisms in mycobacterial culture.

Due to absence of cell clumping, mycobacterial titer in this media can be determined with significantly better accuracy and precision as compared to serum-based media.

MycoClear™ broth also reduces the other costs associated with preparation and the uses of the media for different applications.

MycoClear™ broth ensures the quality and performance of mycobacterial cultures, for multiple applications including pre-clinical, clinical and diagnostic research.

The media can also be effectively used for vaccine production and therapeutic development as it achieves higher density as well as better accuracy of bacterial titer to support the scalability needed for industrial bioprocesses.

MycoClear™ broth provides advantages in regulatory compliance, as it minimizes the use of animal-derived components while ensuring the safety of the final product developed by using this media.